HemoSonics’ Post

Discover the latest insights on how the Quantra Hemostasis System is improving coagulation testing in cardiac surgery. The Anesthesiology News article covers the advantages of point-of-care #POC viscoelastic testing, its role in reducing unnecessary transfusions, and its impact on patient outcomes and healthcare costs. Read the full article to learn more about these important advancements in #PatientBloodManagement. #CardiacSurgery #POCTesting #PatientCare #HealthcareInnovation #Quantra https://bit.ly/46yEnhb

John Friedl

Global Marketing Director @ HemoSonics | Point of Care and Lab Dx

4mo

To end the global problem of overtransfusion, physicians, policymakers, and stakeholders must work together to communicate the risks of overtransfusion and the potential for a better path forward.

Joseph A. Steele

Head of Commercial-US, HemoSonics

4mo

HemoSonics and #Quantra delivers “point of need” support…you decide where adjunct technology best fits with your current needs and we can deliver, regardless of the environment.

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics